Satellites and AI Deployed to Track UK Hedgehog Decline Highlighting Environmental Monitoring Opportunities ASEANBAC and AVPN Launch Regional Platform to Boost Corporate Social Investment in Southeast Asia Jim Cramer Expresses Optimism on Target Corporation TGT US Productivity Growth Slows in Q4 as Unit Labor Costs Rise Signaling Inflationary Pressures Morgan Stanley Adjusts Palo Alto Networks Price Target Amid Shifting Cybersecurity Demand Consumer Prices Surge to 38 Annually in April Exceeding Expectations Ares Commercial Real Estate Corporation ACRE Q1 2026 Earnings Deep Loss Surprises Market as Net Interest Income Weighs 22nd Century Group Q1 2026 Earnings Massive EPS Miss Sparks Investor Concern CMI Q1 2026 Earnings EPS Beat by 897 on Strong Operational Performance UHAL Q1 2026 Earnings EPS Misses Estimates Significantly Stock Rises Despite Loss INGM Q1 2026 Earnings EPS Beats Street Estimates Stock Moves Higher CRS Q1 2026 Earnings EPS Exceeds Expectations Amid Cautious Market Response Andretti Acquisition Corp II POLE Holds Steady Near Trust Value Amid Minimal Volatility Basel Medical Group Ltd BMGL Dips 277 to 060 as Support Test Looms QVC Group Inc QVCGA Holds Steady at 034 Amid Low Volatility Medifast MED Shares Edge Lower Amid Consolidation Near Support Levels Scage Future SCAG Slides 4 Nears Critical Support at 047 Why the Oil Supply Crunch May Be Delayed Key Factors at Play BWEN Q1 2026 Earnings NarrowerThanExpected Loss Drives DoubleDigit Stock Rally CocaCola KO Stock Climbs 182 as Beverage Giant Approaches Key Resistance UNP Q1 2026 Earnings EPS Beats Estimates Amid Strong Operational Performance Atlanticus Holdings ATLCP Q1 2026 Earnings Preferred Stock Reports Strong EPS Beat Stock Rises ESS Q1 2026 Earnings Strong Earnings Beat Driven by Operational Efficiency Enova International Inc Q1 2026 Earnings EPS Surges Past Expectations Amid Strong Operational Execution HLIT Q1 2026 Earnings EPS Smashes Estimates Driving DoubleDigit Stock Surge CLPT Q1 2026 Earnings EPS Misses Estimates as Revenue Details Remain Undisclosed SRPT Q1 2026 Earnings EPS Smashes Estimates by 1847 as Gene Therapy Execution Drives Profit Surprise